posted
seems like other people like this stock too out there, nice to see. i had the wrong OS numbers, just learned its 1 billion OS,ammost positive about that.. that sucks, i thought it was smaller than that, but charts are screaming oversold so i'll stick with it. who knows with these pennies, lol
posted
if they see a bunch of sell orders under 7 they will drag it that low, i have a feeling they will try.. there are a bunch under 7.. ,,mm's marked it, lol
Posts: 6397 | Registered: Jan 2006
| IP: Logged |
posted
hmm, scll needs some news to waken people up that this is a good stock, not off to the best start.
-------------------- Do not trade on my advise, if I have any to give, lol. Up 127% since joined the website. Posts: 205 | From: New England (MA) | Registered: Jan 2007
| IP: Logged |
posted
Wow, when will people realize that every day it jumps up like 5-10% just from overnight trading, then people are bidding it down right away absolutely no point in selling this right now.
-------------------- Do not trade on my advise, if I have any to give, lol. Up 127% since joined the website. Posts: 205 | From: New England (MA) | Registered: Jan 2007
| IP: Logged |
posted
I was in this one not to long ago Cactus, but decided to bail when NITE wasn't letting up on it and I could see when it broke its support that it was going lower. Don't like the bloated OS on this one, but like all POS's they have to let it go sometime. Can't tell how low they are going to take this one though but the chart is screaming oversold and should bounce.
-------------------- "Remember that time is money." Posts: 412 | From: Murfreesboro | Registered: Oct 2006
| IP: Logged |
posted
mm's have been spanked on this one and they are sitting on a ton of shares imo, the vol is insane lately.. i am gambling that mm's have had enough of the selling and will turn the tables.. we'll see
posted
i think the board of directors are sitting at the table handing the computer to one another taking turns bid whacking, lol.. ok.. now its time for CLYP.. BS, lol
Posts: 6397 | Registered: Jan 2006
| IP: Logged |
posted
I am in the process of helping these clueless clowns.. they have good intentions, but not smart about spreading word. been emailing back and forth.. they are a little slow, but i think news on the way, i'll call first thing in morning to follow up.
jmho
this was one email..
Hey,
Should we do something about this? How does one communicate with investors if we don't know who they are?
Jim
On Feb 7, 2007, at 9:51 AM,
> The following email has been generated by a contact form on your website: www.amphioxus.com. Reporting this email as spam will cause your site to be reported for spamming. > > First Name XXXXXXXXX > Email Address: XXXXXXX > Comments: Do you have an Investor relations dept? I am wondering if we will hear an update about the company soon. > > > > > >
James H. Kelly, PhD
President and CEO
Stem Cell Innovations/Amphioxus Cell Technologies, Inc.
Looks like Mare Chassman owns a **** a load of warrants with a strike price of .06 cents. As far as I can tell she owns almost 200 million shares.
Margie Chassman is married to David Blech. Mr. Blech disclaims beneficial ownership of these shares. Since 1980 Mr. Blech has been a founder of companies and venture capital investor in the biotechnology sector. His initial venture investment, Genetic Systems Corporation, which he helped found and served as treasurer and a member of the board of directors, was sold to Bristol Myers in 1986 for $294 million of Bristol Myers stock. Other companies he helped found include DNA Plant Technology, Celgene Corporation, Neurogen Corporation, Icos Corporation, Incyte Pharmaceuticals, Alexion Pharmaceuticals and Neurocrine Biosciences.
Posts: 6397 | Registered: Jan 2006
| IP: Logged |
posted
I placed a limit order, hopefully it will get filled. Nice looking chart, hopefully this can bring me the stability my crazy speculation portfolio needs. Looking for a nice 15% ish outta this.
-------------------- Do not trade on my advise, if I have any to give, lol. Up 127% since joined the website. Posts: 205 | From: New England (MA) | Registered: Jan 2007
| IP: Logged |
posted
it rebounded from under .06 to almost 7 today, but those greedy F's Nite swept in and killed it AGAIN.., could of easily finished over .07.. greed sucks some times, lol.. i cashed out some shares i got at .06 on the flip when i saw nite being evil again. but am holding much more, still think it has life.
posted
Stem Cell Innovations Seeks European Union Registration for Its in vitro Toxicology Suite 9:18a ET February 9, 2007 (Business Wire)
Stem Cell Innovations (SCI), Inc. (OTCBB: SCLL) announced today that the Company has submitted its ACTIVTox(R) in vitro toxicology suite to ECVAM to seek validation as an alternative to animal testing in the European Union. Toxicity testing in the pharmaceutical and chemical industries is often performed in rodents. The use of ACTIVTox would reduce the need for animals in clinical testing, saving pharmaceutical companies time and money.
ACTIVTox, SCI's proprietary highly characterized human liver cell system, is currently being used to accurately predict the response of the liver to a new drug compound. Chemists can then eliminate potential toxicity before entering clinical trials. ACTIVTox is reproducible, relevant to the human and compatible with modern high throughput drug discovery. In addition, ACTIVTox has broad application and can be used to examine toxicity in chemicals, nutraceuticals and cosmetics.
ECVAM was created by a Communication from the European Commission to the Council and the Parliament in October 1991, pointing to a requirement in Directive 86/609/EEC on the protection of animals used for experimental and other scientific purposes, which requires that the Commission and the Member States should actively support the development, validation and acceptance of methods which could reduce, refine or replace the use of laboratory animals.
"Obtaining ECVAM approval for ACTIVTox in Europe is part of SCI's strategy to become a leading provider of alternatives for animal experiments," said CEO Dr. James Kelly. "Using our proprietary human cell models in combination with our in depth biology expertise, we will be in an excellent position to rapidly broaden our portfolio with new in vitro tests that help to reduce the number of animals used in the pharmaceutical industry."
About Stem Cell Innovations, Inc.
SCI is a cell biology company with facilities in Scotch Plains, NJ, Houston, TX and in Leiden, the Netherlands. Stem Cell Innovations proprietary, human pluripotent stem cells, known as PluriCells(TM), have the potential to aid in drug discovery, toxicology, and cell therapy.
Stem Cell Innovations is positioned to become a leading provider of toxicology testing and discovery systems for the pharmaceutical, chemical, and nutraceutical industries around the world. The development of the proprietary PluriCell(TM) technology greatly expands the Company's currently marketed C3A human liver cell-based toxicology offerings.
Posts: 6397 | Registered: Jan 2006
| IP: Logged |
posted
why am i not surprised CLYP 7 ticks under everyone bid whacking.. some greedy f's own this, thats for sure
Posts: 6397 | Registered: Jan 2006
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
. I got all the time in the world lol.
![[Confused]](confused.gif)
